Crimean-Congo Hemorrhagic Fever in South Africa

Swanepoel, Robert; Struthers, J. K.; Shepherd, A. J.; McGillivray, Gillian; Nel, M. J.; Jupp, P. G.

doi:10.1007/978-1-4020-6106-6_11

Cited by 34 publications

(3 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Between 1981 and 2006, 44% of CCHF cases in southern Africa reported a tick bite, 40% reported contact with livestock blood or tissue, 12% of cases did not report any direct contact with livestock or tick bite but lived in or visited rural areas, and 4% of cases were infected nosocomially. During the same time frame, the majority of CCHF cases were men (83%) [ 86 ].…”

Section: Worldwide Burden and Phylogenetics Of Cchfvmentioning

confidence: 99%

Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe

et al. 2021

View full text Add to dashboard Cite

The global spread of ticks and various tick-borne viruses (TBVs) suggests the possibility of new tick-borne diseases emerging. Crimean-Congo hemorrhagic fever virus (CCHFV) is an emerging TBV of the Nairoviridae family that causes serious disease that can be fatal in humans. CCHFV endemic foci can be found in Africa, Asia, the Middle East, and South-Eastern Europe, and has spread to previously unaffected regions and nations, such as Spain, over the last two decades. In this review, we discuss the current situation of CCHFV in Asia, Africa and Europe based on existing knowledge, and we discuss driving factors in the distribution and transmission of the virus, such as the spread of tick vector species and host reservoirs.

show abstract

Section: Worldwide Burden and Phylogenetics Of Cchfvmentioning

confidence: 99%

Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe

et al. 2021

View full text Add to dashboard Cite

show abstract

“…It is worsened by the asymptomatic infection or mild fever that the disease causes in domestic and wild vertebrates with a detectable viremia of up to 14 days (9,10). In the same way, the diseased ostriches show merely low and short-lived viremia without any clinical manifestations (11). As such, new infections in animals are usually undiagnosed and approaches like polymerase chain reaction (PCR), isolating the virus in cell culture, and IgM detection using enzyme-linked immunosorbent assay (ELISA) are mostly applied in diagnosing CCHF in humans or when an animal is required to be considered CCHF-free.…”

Section: Introductionmentioning

confidence: 99%

Seroprevalence of Crimean Congo Hemorrhagic Fever in cows by ELISA in Mosul city

Esmaeel¹,

Hussain²,

Altaliby³

2021

IJVS

View full text Add to dashboard Cite

Crimean-Congo hemorrhagic fever (CCHF) is described as a tick-borne viral zoonosis highly prevalent in Africa, Asia, Russia and the Balkans within the distribution range of ticks that belong to the genus Hyalomma. This research aimed to verify the seroprevalence of CCHF in cows employing Indirect enzyme-linked immunosorbent assay (I-ELISA) in Mosul city / Iraq, to examine some epidemiological risk factors related to the incidence of CCHF. From October 2019 -September 2020, one hundred eighty-four blood samples were taken from 3-8-year-old cattle of both sexes, from several management systems and origins, from various parts in Mosul city, 10 ml of blood was taken from the jugular vein in test tubes without anticoagulant to obtain the sera for I-ELISA test, while epidemiological data were obtained by interviewing the farm-owners. I-ELISA was applied to detect the antibodies of CCHF in the serum. The overall seroprevalence of CCHF in cows was 40/184 (21.7%). As for the risk factors associated with increased seroprevalence of the disease, an increase in seroprevalence rates was observed at ages 6, 7 and 8 years 30.5%, among females 26.3% and imported animals 27.5%. which showed that the serological prevalence in indoor feeding and outdoor feeding, was not significantly different (p<0.05). This study concluded that there is a higher seroprevalence of CCHF in Mosul city along with many risk factors related to its incidence.

show abstract

“…общее число зарегистрированных случаев кГЛ в мире к 2012 г. составило более 7924: 2180 в российской федерации [6,7], 1554 в болгарии, 8 в Албании, 264 в косово [8], 211 на территории Украины (крым и Луганская область) [7], 1820 в турции [9][10][11], 1 в Греции [12], 1 в Грузии [13], 286 в китае [4], 260 в казахстане [7,14], 144 в таджикистане [7], 29 в Пакистане [4,15], 3 в киргизии [4], 553 в Узбекистане, 1 в Армении [7], 79 в Афганистане [16], 17 в кувейте [17], 10 в туркмениста-не [7], 18 в объединенных Арабских Эмиратах, 94 в ираке [4,18], 81 в иране, 5 в омане [4,19], 40 в саудовской Аравии [20] и 265 в странах Африки (Демократическая республика конго, Уганда, Мавритания, буркина-фасо, Южно-Африканская республика, танзания, Намибия, судан, кения, сенегал) [4,[21][22][23][24] (табл. 1).…”

unclassified

Morbidity of the Crimean Hemorrhagic Fever in the Countries of Europe, Africa and Asia (1943-2012)

Бутенко

Трусова

2013

Epidemiology and Infectious Diseases

View full text Add to dashboard Cite

In the article there is presented the most complete to date information on the incidence of Crimean hemorrhagic fever (CHF) in endemic countries in Europe, Africa and Asia, with allowances made for the first publications in the 40-ies of XX century to 2012. According to available sources, the total number of cases of CHF in this period was 7924, out of which 2180 in the Russian Federation, 1820 in Turkey, 1554 in Bulgaria, 553 in Uzbekistan, 286 in China, 264 in Kosovo, 260 in Kazakhstan, 265 in Africa (including 180 in South Africa).

show abstract

Crimean-Congo Hemorrhagic Fever in South Africa

Cited by 34 publications

References 33 publications

Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe

Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe

Seroprevalence of Crimean Congo Hemorrhagic Fever in cows by ELISA in Mosul city

Morbidity of the Crimean Hemorrhagic Fever in the Countries of Europe, Africa and Asia (1943-2012)

Contact Info

Product

Resources

About